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An evaluation ofthe Advanced micro-osmometer is presented. This
instrument has been shown to have an excellent analytical precision
(within-run CV 0"59%, between-@ CV 0"58%). It is
accurate over an analytical range ofO-2000 mmol/kg ofosmolality
shown by linearity studies and split sample correlations against
vapour pressure osmometry, freezing point osmometry and an
external quality assurance programme. Analytical errors due to
operator technique are almost eliminated because ofgood instrument
design. Preliminary results on whole-blood osmolality are included.
The required sample size of 20 bl permits osmolality measure-
ments on most clinical samples. It is concluded that the Advanced
micro-osmometer satisfies laboratory requirements.
Introduction
Changes in departmental requirements concerning the
measurement of fluid osmolality initiated this study. Our
laboratory is currently equipped with instrumentation
that utilizes the principle of vapour pressure osmometry
but, because of the poor performance of this procedure in
our external quality assurance programme, it was
decided to investigate the osmolality of solutions by
measurement offreezing point depression, as this method
has been shown to perform well in such programmes.
Freezing point in osmometry is that temperature (at
atmospheric pressure) at which the solid and liquid
phases will co-exist in equilibrium. When a solute is
dissolved in a pure solvent, the colligative properties of
the solvent usually change in direct proportion to the
solute concentration. Measurement of the freezing point
allows concentrations to be determined with greatest
precision owing to the inherent isolation of the sample
from the environment by the iced blanket generated when
the sample freezes.
Apart from the analytical principle requirement, sample
size was an important consideration. We perform sweat
osmolalities for the detection of cystic fibrosis as de-
scribed by Webster and co-workers [1-3] using a
collection procedure described by Carter et al. [4] and
receive paediatric samples and body fluids not easily
obtained in large amounts. Primary selection of instru-
ments was based on impressions gained from commercial
advertising and it was decided to assess the performance
of the Model 3MO Advanced micro-osmometer (Advan-
ced Instruments, Needham Heights, MA, USA).
Experimental
The Advanced micro-osmometer was supplied by Stan-
sens Scientific (Sydney, Australia) for this study. This
instrument uses 20 1 of sample to measure sample
osmolality by freezing point depression. Supercooling of
the sample is initiated by the insertion of a specially
designed, disposable sample holder containing the
sample into the instrument’s thermistor probe, which is
in a fixed position. Following a solenoid-induced pulse
and subsequent sample freezing, the liberated heat of
fusion is related by a microprocessor to the sample’s
freezing point and osmolality is shown on a digital
display. Calibration of the instrument requires no adjust-
ment by the operator. It consists ofrunning 2-6 samples
at each oftwo calibration levels (50 and 850 mmol/kg). If
the repeatability is acceptable, the instrument automatic-
ally performs internal calibration.
Samples
Within-run precision. Five types of sample were used in
order to evaluate the repeatability of the instrument.
Aqueous, commercially available solutions of50, 290 and
850 mmol/kg (Advanced Instruments, P.N. 3MA005,
Clinitrol 290 and 3MA085, respectively), plasma
obtained by centrifugation from lithium heparinized
whole blood, whole blood, three 24-h urine samples
collected with 5 g of thymol and pooled eccrine sweat
collected from volunteers by pilocarpine iontophoresis
using the Webster Model 3600 sweat inducer and
microduct kit (Webster Scientific, Sydney, Australia).
Each sample was analysed ten times (except the sweat
sample, which was analysed five times) in a single batch
and on the same day. The osmolalities measured were
selected to span the instrument’s analytical range of
0-2000 mmol/kg.
Between-@ precision. To avoid sample evaporation and
subsequent changes in sample osmolality, samples selec-
ted for this part of the study were refrigerated throughout
and an effort was made to exclude as much air as possible
from the sample tube. Prior to each analysis, aliquots
were brought to room temperature and analysed in
random order amongst a run ofother specimens. Samples
were selected from patients and quality control material,
with appropriate osmolality levels, and analysed in
duplicate on nine separate runs over a period of eight
days.
Accuracy studies. Ninety-four samples were selected from
patients’ plasma and urine specimens analysed by the
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Wescor vapour pressure osmometer so that the levels of
osmolality were distributed throughout the analytical
range. Haemolysed, lipaemic and icteric specimens were
also included. These samples were analysed in duplicate
with the micro-osmometer. In addition, the accuracy of
the micro-osmometer was also investigated by analysing
25 urine and plasma samples with both the Advanced
micro-osmometer and a Knauer semi-micro osmometer
(Knauer, Berlin, FRG), which also utilizes freezing point
depression thermodynamics. In addition, 11 lyophilized
samples with target values previously assigned and
linearly related were obtained from the Royal College of
Pathologists of Australasia Quality Assurance Pro-
gramme (Target Kit No. 13, Samples 1-11), reconsti-
tuted and analysed in duplicate with the Advanced
micro-osmometer.
Linearity studies. A urine sample with an osmolality of 1918
mmol/kg was selected and 0-,. 0"2-, 0"4-, 0"6-, 0"8- and
l’0-ml aliquots were pipetted into test-tubes in duplicate.
Into each of the aliquots 1.0, 0"8, 0"6, 0"4, 0"2 and 0 ml of
distilled water were added in sequence, resulting in six
diluted samples with calculated osmolalities of 0, 384,
767, 1150, 1534 and 1918 mmol/kg, respectively. Both
sets of aliquots were analysed in duplicate with the
micro-osmometer in two different analytical batches.
Whole-blood osmolality. Thirty-four heparinized samples
submitted to the laboratory for routine biochemical
analysis were used to measure whole-blood osmolality.
Each sample was analysed for osmolality and after
centrifugation the plasma osmolality was measured.
Between-operator variation. Because of the small amount of
sample required to perform each analysis on the micro-
osmometer, we decided to measure the instrument’s
dependence on operator technique. Seven members ofthe
laboratory staff were selected from five technical and
professional types. Each was instructed on the basic
operation of the instrument and was then given a sample
to analyse ten times.
Results
Within-run precision
The results are shown in table 1. The samples selected
spanned an analytical range of 37-1917 mmol/kg,
sufficient to cover expected results most often submitted
Table 1. Within-run precision
No. of Mean SD
analyses (mmol/kg) (mmol/kg) CV (%) Sample type
10 36"7 0"49 1"30 Urine
10 49"8 0"42 0’85 Aqueous
5 124"0 0"92 0-74 Eccrine sweat
10 289’3 0"48 0" 17 Aqueous
10 293"4 2"98 1"02 Whole blood
10 295"6 1"00 0"35 Plasma
10 557"6 0"97 0" 17 Urine
10 852"4 1"76 0"21 Aqueous
10 1917"6 9"20 0"48 Urine
Table 2. Between-@ precision
No. of Mean SD Sample
runs Target (mmol/kg) (mmol/kg) CV (%) type
9 37 36"2 0"45 1"20 Urine
9 290 287"9 1"09 0"38 Plasma
9 569 568" 2" 14 0"38 Urine QC*
9 1026 1026 3"53 0"34 Urine Qc-
* Lyphocheck Quantitative urine control Normal (I), Lot No.
15300.
J" Lyphocheck Quantitative urine control Abnormal (II), Lot
No. 15400.
to our laboratory for routine analysis. Acceptable stan-
dard deviations (SD) and coefficients of variations (CV)
of 0" 17-1.30% (average 0"59%) were obtained.
Between-day precision
The results are shown in table 2. The four levels of
osmolality selected, representing clinically significant
values, exhibit CVs of 0"34-1"20% (average 0"58%),
which is satisfactory.
Accuracy
As shown in figure a, a split sample comparison between
vapour pressure and freezing point measurements indi-
cates good agreement. However, it is important to note
that calibration of the Wescor vapour pressure
osmometer is performed with aqueous standards having
osmolality values established by our laboratory. For this
reason, two additional accuracy studies were performed.
First, a split sample comparison was made between the
Advanced micro-osmometer and another freezing instru-
ment (Knauer). As a result, a regression line ofy 2"5
1.0x was calculated with a correlation coefficient of
0"9999. Second, osmolality values obtained with the
Advanced micro-osmometer from samples were com-
pared with values established by an external assessor,
with satisfactory results (figure b).
Linearity
Table 3 indicates that the Advanced micro-osmometer
gives a linear response up to at least 1917 mmol/kg. It is
also interesting that the diluent used (distilled water, tube
1) has a value of mmol/kg. Distilled water measure-
ments with the vapour pressure osmometer resulted in
osmolalities of 30-50 mmol/kg, indicating a possible
deviation from linearity at low levels or contamination of
the measuring chamber.
Operator variation
Previous experience had taught us to investigate this
important, but often neglected variable. This becomes
even more important if micro-amounts of sample are
required by the analytical principle. Table 4 shows a CV
range of 0"17-0"81% (average 0"49%) with accuracy
deviations of less than 1% for all of the seven operators
involved.
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Figure 1. Graphical representation of(a) split sample comparison
of osmolality measurements by the Wescor vapour pressure and
Advanced 3MO osmometers, (b) freezing point osmolality
measurements of 11 external quality assurance samples and (c)
whole-blood versus plasma osmolality measured byfreezing point
depression.
Table 3. Linearity
Sample Diluent Error
Tube (ml) (ml) Result* Result* Mean (%)
0.0 1.0
2 0.2 0.8 381 386 383.5 -0.13
3 0.4 0.6 769 762 765.5 -0.20
4 0.6 0-4 1140 1135 1138 1.00
5 0.8 0-2 1420 1530 1525 -0.59
6 1.0 0.0 1904 1918 1911 -0.31
Regression analysis:
Slope 0"9947
Intercept 0-41
Correlation coefficient (r) 0"9999
* Mean of duplicate measurements (mmol/kg).
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Table 4. Between-operator variation
Number Target* Mean SD
of (mmol/(mmol/(mmol/ CV Accuracy Operator
analyses kg) kg) kg) (%) (%) type
10 296 295"6 1.00 0"35 -0" 14 Senior
scientific
10 296 295"2 0"92 0"31 -0"27 Senior
technical
10 279 277"7 1"77 0’64 -0"47 Senior
scientific
10 401 403"6 0"70 0’17 +0’65 Technical
10 285 283"7 2"30 0"81 -0"46 Technical
10 286 288"0 2’11 0"73 +0"70 Trainee
scientific
10 296 296"2 1"78 0"60 +0"07 Trainee
technical
* Target values established from previous measurements.
Whole-blood osmolality
Although a relatively small number of samples were
analysed (n 34) for whole-blood osmolality, the results
shown in figure c indicate a high correlation between
plasma and heparinized whole-blood samples. Note that
in table a CV of 1"02% was calculated, which compares
with CVs of 0.17% at 290 mmol/kg and 0"35% at 295
mmol/kg for similar plasma measurements.
Discussion
Our experience over the last 2 years with vapour pressure
measurements of osmolality with all types of samples
commonly submitted to a clinical laboratory (including
sweat) has shown that this procedure lacks the precision
and accuracy required by our laboratory, and this was
confirmed by this study. We measured precision of our
vapour pressure osmometer (unpublished results) and
the CV was found to be of the order of 3"3-4"9% for an
osmolality range of 74-1000 mmol/kg. Similar findings
were reported by Davis [5] and Kaplan [6] in CAP
quality assurance surveys and by the Royal College of
Pathologists of Australasia in quality assurance surveys
in the last 2 years [7,8]. This type of measurement also
tends to produce lower results by an average ofabout 3%
throughout the analytical range [5-8] which led us to
alter the calibration values ofprimary standards in order
to compensate for this effect.
The introduction of the Advanced micro-osmometer with
a small sample requirement (20 1) should enable the
analyst to perform freezing point measurements with
higher precision and accuracy than with earlier models of
such instruments with larger sample size requirements.
This evaluation of the Advanced micro-osmometer has
shown excellent precision and accuracy throughout the
analytical range prescribed by the manufacturer. The
CVs for within-run (table 1) and between-day (table 2)
imprecision are well within acceptable limits using five
different types of samples. It is linear throughout the
analytical range, especially at low values, which will now
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whereas this was not possible with earlier models using
the freezing point depression principle.
It is recognized that any analytical procedure is more or
less susceptible to errors introduced by operator tech-
niques and expertise. In this instance, we measured this
important factor and the results shown in table 4 indicate
a range of CVs between 0"17 and 0.81% with less than
0"7% deviation in analytical accuracy.
The high degree of precision exhibited by the Advanced
micro-osmometer could be explained by examining the
attempts made by the manufacturer to minimize factors
that contribute to a loss of precision with conventional
instruments. For example, bath temperature control,
which is dependent on the fluid used, amount offluid and
volume changes as moisture condenses from the room air,
may be important. The supercooling ofthe sample should
be rapid but at a controlled rate. The Advanced
instrument uses no fluid in the cooling chamber; instead,
temperature is controlled by an electronically adjusted
thermoelectric module that provides steady supercooling
of the sample. The probe senses the temperature in the
sample cell. Because the probe sees only a small portion of
the sample space, it is important that the sample
temperature be uniform. This is achieved by the stan-
dardized sample cuvettes which fit perfectly with the
sample port. In addition, if the tip of the probe is not
positioned repeatably from sample to sample, the preci-
sion may suffer. The tip of the probe in the Advanced
instrument is in a fixed position and the sample port
provides for repeatable positioning and centring of the
sample in the probe. In most instruments the probe needs
to be wiped in order to minimize carryover from sample
to sample, and in laboratories with a large number ofstaff
operating the instrument insufficient or incorrect clean-
ing could be encountered. Cleaning of the probe in the
Advanced instrument is another regulated procedure
which will ensure a clean chamber and probe each time
with any operator.
Rocks et al. [9], using a freezing point osmometer,
measured whole-blood osmolality and reported this to be
an average of 1"5 mmol/kg higher than that of plasma.
Certain factors must be considered if whole-blood osmo-
lality is to be measured. These include effects of lithium
heparin on whole-blood osmolality, effect of the packed
cell volume and haemolysis. We did not investigate these
effects in this work, but we are in the process of defining
them in a much larger study. However, as it has been
reported that the above factors may have no effect on
osmolality measurements by freezing point depression
[9], we have shown preliminary results in figure lc.
Our results are in agreement with those ofRocks et al., but
we found whole-blood osmolality to be about 4.0 mmol/
kg higher than plasma osmolality using lithium hep-
arinized samples. It is believed that this is due to an
artificial elevation caused by anaerobic glycolysis in the
samples, which is unavoidable unless whole-blood osmo-
lality is measured within h of collection, and we intend
to address this problem. Notwithstanding the above
limitation, whole-blood osmolality could prove to be a
very useful measurement, especially with subjects where
sample size is of importance.
In conclusion, we have found the Advanced micro-
osmometer to be a very precise and accurate instrument
for the measurement of osmolality with a high degree of
linearity throughout a wide analytical range, and the
instrument design has almost entirely eliminated ana-
lytical errors introduced by operator techniques.
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